Peter E. Schwartz, MD | Authors

""INTERNAL MEDICINE ASSOCIATES OF FRANKFORT, PSC""

101 MEDICAL HEIGHTS DR STE M

Articles

What Is the Role of Neoadjuvant Chemotherapy in the Management of Ovarian Cancer?

September 02, 2008

Conventional therapy for advanced-stage ovarian cancer-ie, aggressive cytoreductive surgery followed by aggressive chemotherapy-was established more than 3 decades ago [Editor’s note: See Dr. Schwartz’s article, “Cytoreductive Surgery in the Management of Ovarian Cancer,” in last month’s issue of ONCOLOGY]. Since that time, no prospective randomized trials have been reported to confirm the efficacy of this treatment strategy.

Cytoreductive Surgery in the Management of Ovarian Cancer

August 01, 2008

The standard management for advanced-stage ovarian cancer was established in the mid-1970s. At a 1974 National Cancer Institute Consensus Conference on Ovarian Cancer, Griffiths presented data supporting the role for aggressive cytoreductive surgery as the first step in the management of this disease, followed by cytotoxic chemotherapy.